Has Daniel Engelman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $607,410 in general payments to Daniel Engelman, MD across 396 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Engelman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Engelman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Engelman, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Springfield, MANPI 1366468894

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $531,249 of the $607,410 with a category attached, or 87.5%. Arthrex accounts for 60.1% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $268,244, 8.5 times the $31,699 reported in 2019. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$607,410in general payments, 2019–2025

Across 396 payments — averaging $1533.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$365K
AstraZeneca$100K
Edwards Lifesciences$82K
Biomerieux Inc$9K
Abiomed$9K
Medela AG$9K
plus $34K from 14 others

$393,132in research payments, 2019–2025

Across 76 payments — averaging $5172.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$334K
AstraZeneca$60K

What the payments were for

Consulting fees$531,24987%
Speaking & faculty fees$24,6354%
Travel & lodging$44,3337%
Food & beverage$7,1941%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	234	$364,835
AstraZeneca	41	$99,808
Edwards Lifesciences	59	$81,746
Biomerieux Inc	9	$9,462
Abiomed	11	$9,430
Medela AG	4	$8,625
Grifols Shared Services North America, Inc.	9	$6,942
Chugai Pharmaceutical Co., Ltd.	2	$6,824
Atricure, Inc.	9	$5,811
Pharmacosmos Therapeutics Inc.	3	$5,203
Astellas Pharma Inc	3	$4,038
Rockwell Medical, Inc.	1	$3,000
Masimo Corporation	1	$640
Medela LLC	2	$290
Terumo Cardiovascular Systems Corporation	2	$262
BD	2	$165
Haemonetics Corporation	1	$137
Hemosonics LLC	1	$98
Supreme Orthopedic Systems, LLC	1	$48
La Jolla Pharmaceutical Company	1	$46

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ULTOMIRIS$86,469
Edwards SAPIEN 3 Transcatheter Heart Valve$49,700
SHOULDER SUTURE CERCLAGE CERCLAGE$11,616
NEPHROCHECK TEST$9,282
SYNERGY ABLATION SYSTEM$5,583
Monoferric$5,203
TRIFERIC$3,000
Thopaz$2,875
Dominant Flex$220
TEG6s HEMOSTASIS SYSTEM$137
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$137

How this compares

$607,410 in reported general payments places this provider in the 95th percentile of 171 thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$15,383

Medicare patients

Services billed

104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Springfield

David DeatonSpringfield$51K
Ruchi ThanawalaSpringfield$27K
Laki RousouSpringfield$25K
David BullSpringfield$23K
Elliot ServaisBurlington$689K
Daniel RaessBoxford$429K
Lana Schumacher BealBoston$254K
Sidney LevitskyBoston$248K
Robert ThurerBoston$229K
Margaret MarshallBoston$122K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →